The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Of sound mind and body: depression, disease, and accelerated aging
Open accessAbstract
Major depressive disorder (MDD) is associated with a high rate of developing serious medical comorbidities such as cardiovascular disease, stroke, dementia, osteoporosis, diabetes, and the metabolic syndrome. These are conditions that typically occur late in life, and it has been suggested that MDD may be associated with "accelerated aging." We review several moderators and mediators that may accompany MDD and that may give rise to these comorbid medical conditions. We first review the moderating effects of psychological styles of coping, genetic predisposition, and epigenetic modifications (eg, secondary to childhood adversity). We then focus on several interlinked mediators occurring in MDD (or at least in subtypes of MDD) that may contribute to the medical comorbidity burden and to accelerated aging: limbic-hypothalamic-pituitary-adrenal axis alterations, diminution in glucocorticoid receptor function, altered glucose tolerance and insulin sensitivity, excitotoxicity, increases in intracellular calcium, oxidative stress, a proinflammatory milieu, lowered levels of "counter-regulatory" neurosteroids (such as allopregnanolone and dehydroepiandrosterone), diminished neurotrophic activity, and accelerated cell aging, manifest as alterations in telomerase activity and as shortening of telomeres, which can lead to apoptosis and cell death. In this model, MDD is characterized by a surfeit of potentially destructive mediators and an insufficiency of protective or restorative ones. These factors interact in increasing the likelihood of physical disease and of accelerated aging at the cellular level. We conclude with suggestions for novel mechanism-based therapeutics based on these mediators.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Child abuse: Adolescent records vs. adult recall
Femina, D. D., Yeager, C. A., & Lewis, D. O. (1990) · Child Abuse & Neglect · doi:10.1016/0145-2134(90)90033-p · Cited by 8,820
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Anda, R. F., Felitti, V. J., Bremner, J. D., Walker, J. D., Whitfield, C., Perry, B. D., Dube, S. R., & Giles, W. H. (2006) · European archives of psychiatry and clinical neuroscience · doi:10.1007/s00406-005-0624-4 · Cited by 4,292
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse
McGowan, P. O., Sasaki, A., D'Alessio, A. C., Dymov, S., Labonté, B., Szyf, M., Turecki, G., & Meaney, M. J. (2009) · Nature Neuroscience · doi:10.1038/nn.2270 · Cited by 3,531
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
Accelerated telomere shortening in response to life stress
Epel, E. S., Blackburn, E. H., Lin, J., Dhabhar, F. S., Adler, N. E., Morrow, J. D., & Cawthon, R. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407162101 · Cited by 3,002
Causal Relationship Between Stressful Life Events and the Onset of Major Depression
Kendler, K. S., Karkowski, L. M., & Prescott, C. A. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.6.837 · Cited by 2,566
Association between telomere length in blood and mortality in people aged 60 years or older
Cawthon, R. M., Smith, K. R., O'Brien, E., Sivatchenko, A., & Kerber, R. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12384-7 · Cited by 1,761
The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders
Heim, C., Ehlert, U., & Hellhammer, D. H. (2000) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(99)00035-9 · Cited by 1,688 · cited 1×
“Pathologically elevated or diminished GC activity might have adverse neurobehavioral and physical health sequellae.(72,75) Chronic hypercortisolemia, in particular, has been proposed by Sapolsky and others(16) to result in a biochemical “cascade,” which can culminate in cell endangerment or cell death in certain cells…”
Risch, N., Herrell, R., Lehner, T., Liang, K.-Y., Eaves, L., Hoh, J., Griem, A., Kovacs, M., Ott, J., & Merikangas, K. R. (2009) · JAMA · doi:10.1001/jama.2009.878 · Cited by 1,655
Oberlander, T. F., Weinberg, J., Papsdorf, M., Grunau, R., Misri, S., & Devlin, A. M. (2008) · Epigenetics · doi:10.4161/epi.3.2.6034 · Cited by 1,432
Allostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging
Seeman, T. E., McEwen, B. S., Rowe, J. W., & Singer, B. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081072698 · Cited by 1,385 · cited 1×
“The “cost” to the organism of maintaining these physiological responses over prolonged periods has been termed “allostatic load”(13) or “arousal pathology,”(14) and it has repeatedly been associated with poor medical outcomes.(12) In addition to chronicity of the stress response, certain psychological, environmental,…”
Lasting epigenetic influence of early-life adversity on the BDNF gene
Roth, T. L., Lubin, F. D., Funk, A. J., & Sweatt, J. D. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.028 · Cited by 1,273
Psychobiology and molecular genetics of resilience
Feder, A., Nestler, E. J., & Charney, D. S. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2649 · Cited by 1,272 · cited 2×
“Biochemical aspects of resilience vs stress vulnerability will not be covered here but have recently been reviewed.(28)”
Fries, E., Hesse, J., Hellhammer, J., & Hellhammer, D. H. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.04.006 · Cited by 1,204 · cited 1×
“Elevated circulating GC levels are often observed in depressed individuals (especially in those with severe, melancholic, psychotic, or inpatient depressions), although considerable variability exists between studies, between individuals, and even within individuals over time, and some individuals are even hypocortiso…”
Dynamic DNA methylation programs persistent adverse effects of early-life stress
Murgatroyd, C., Patchev, A. V., Wu, Y., Micale, V., Bockmühl, Y., Fischer, D., Holsboer, F., Wotjak, C. T., Almeida, O. F. X., & Spengler, D. (2009) · Nature Neuroscience · doi:10.1038/nn.2436 · Cited by 1,162
Weaver, I. C. G., Champagne, F. A., Brown, S. E., Dymov, S., Sharma, S., Meaney, M. J., & Szyf, M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3652-05.2005 · Cited by 905
Childhood trauma associated with smaller hippocampal volume in women with major depression
Vythilingam, M., Heim, C., Newport, J., Miller, A. H., Anderson, E., Bronen, R., Brummer, M., Staib, L., Vermetten, E., Charney, D. S., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.12.2072 · Cited by 812
Pace, T. W. W., Mletzko, T. C., Alagbe, O., Musselman, D. L., Nemeroff, C. B., Miller, A. H., & Heim, C. M. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1630 · Cited by 810
The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death
Sapolsky, R. M. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00971-9 · Cited by 699 · cited 2×
“Prolonged LHPA axis dysregulation can lead to neuroendangering or neurotoxic effects in vulnerable brain regions (eg, prefrontal cortex and hippocampus).(16) It can also lead to energetic disturbances (decreased intracellular glucose availability and insulin resistance), glutamatergic hyperactivity/excitotoxicity, inc…”
Depression and immune function
Kiecolt-Glaser, J. K., & Glaser, R. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00309-4 · Cited by 571
Simon, N. M., Smoller, J. W., McNamara, K. L., Maser, R. S., Zalta, A. K., Pollack, M. H., Nierenberg, A. A., Fava, M., & Wong, K.-K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.004 · Cited by 516
Heim, C., Plotsky, P. M., & Nemeroff, C. B. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300397 · Cited by 514 · cited 1×
“Alterations in LHPA axis activity (increased or decreased) have been well described in victims of childhood adversity, even when the individuals are not currently depressed.(27,30) In fact, several instances of neurobiological changes reported in MDD may be more attributable to histories of early-life adversity,(30,32…”
Berk, M., Copolov, D. L., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., & Bush, A. I. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.022 · Cited by 500
Cell aging in relation to stress arousal and cardiovascular disease risk factors
Epel, E. S., Lin, J., Wilhelm, F. H., Wolkowitz, O. M., Cawthon, R., Adler, N. E., Dolbier, C., Mendes, W. B., & Blackburn, E. H. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.08.011 · Cited by 450 · cited 1×
“Prolonged activation of central NE systems, as often seen in melancholic depression, may be associated with worsened outcome in cardiovascular diseases and with accelerated cell aging at the level of the telomere.(9,15) In addition to increases in these destructive processes, normal compensatory or reparative processe…”
Self-citationKiecolt-Glaser, J. K., Gouin, J.-P., Weng, N.-P., Malarkey, W. B., Beversdorf, D. Q., & Glaser, R. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31820573b6 · Cited by 430
Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties
Rupprecht, R. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00064-1 · Cited by 427
Wolkowitz, O. M., Mellon, S. H., Epel, E. S., Lin, J., Dhabhar, F. S., Su, Y., Reus, V. I., Rosser, R., Burke, H. M., Kupferman, E., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017837 · Cited by 421
Self-citationSelective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes
Griffin, L. D., & Mellon, S. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13512 · Cited by 387 · cited 1×
“Selective serotonin reuptake inhibitor (SSRI) antidepressants rapidly increase allopregnanolone synthesis, and this may contribute to their anxiolytic effects.(77,78) Another neurosteroid, DHEA, which may have “anticortisol” effects, has been reported to be both high and low in depression.”
Self-citationAllostasis, amygdala, and anticipatory angst
Schulkin, J., McEwen, B. S., & Gold, P. W. (1994) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(94)90051-5 · Cited by 380
Progesterone metabolite allopregnanolone in women with premenstrual syndrome
RAPKIN, A., MORGAN, M., GOLDMAN, L., BRANN, D., SIMONE, D., & MAHESH, V (1997) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(97)00417-1 · Cited by 376
Reduced telomerase activity in human T lymphocytes exposed to cortisol
Choi, J., Fauce, S. R., & Effros, R. B. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.12.004 · Cited by 352
Interleukin-6 Covaries Inversely with Hippocampal Grey Matter Volume in Middle-Aged Adults
Marsland, A. L., Gianaros, P. J., Abramowitch, S. M., Manuck, S. B., & Hariri, A. R. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.016 · Cited by 348
Obesity and Type 2 Diabetes Risk in Midadult Life: The Role of Childhood Adversity
Thomas, C., Hyppönen, E., & Power, C. (2008) · Pediatrics · doi:10.1542/peds.2007-2403 · Cited by 330
Denson, T. F., Spanovic, M., & Miller, N. (2009) · Psychological Bulletin · doi:10.1037/a0016909 · Cited by 328
Can Meditation Slow Rate of Cellular Aging? Cognitive Stress, Mindfulness, and Telomeres
Epel, E., Daubenmier, J., Moskowitz, J. T., Folkman, S., & Blackburn, E. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04414.x · Cited by 324
Frank, M. G., Miguel, Z. D., Watkins, L. R., & Maier, S. F. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.07.008 · Cited by 303
Depression gets old fast: do stress and depression accelerate cell aging?
Wolkowitz, O. M., Epel, E. S., Reus, V. I., & Mellon, S. H. (2010) · Depression and Anxiety · doi:10.1002/da.20686 · Cited by 298
Self-citationPatchev, V (1996) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00096-6 · Cited by 283 · cited 2×
“Allopregnanolone or allotetrahydrodeoxycorticosterone can also attenuate stress-induced increases in plasma ACTH and corticosterone and can affect arginine vasopression transcription in the hypothalamus (paraventricular nucleus).(18) Under chronic stress or in psychiatric disorders, dysregulation of the HPA axis could…”
Should Depressive Syndromes Be Reclassified as “Metabolic Syndrome Type II”?
McIntyre, R. S., Soczynska, J. K., Konarski, J. Z., Woldeyohannes, H. O., Law, C. W. Y., Miranda, A., Fulgosi, D., & Kennedy, S. H. (2007) · Annals of Clinical Psychiatry · doi:10.1080/10401230701653377 · Cited by 277
Kananen, L., Surakka, I., Pirkola, S., Suvisaari, J., Lönnqvist, J., Peltonen, L., Ripatti, S., & Hovatta, I. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010826 · Cited by 270 · cited 1×
“Interestingly, individuals with histories of early-life adversity or abuse also have shortened leukocyte telomeres.(36,42,43) Since individuals with MDD are more likely to have experienced earlylife adversity, it remains to be determined how much of the telomere shortening seen in studies of MDD relate to the MDD per…”
Tyrka, A. R., Price, L. H., Gelernter, J., Schepker, C., Anderson, G. M., & Carpenter, L. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.05.012 · Cited by 264
Childhood trauma associated with short leukocyte telomere length in posttraumatic stress disorder
O'Donovan, A., Epel, E., Lin, J., Wolkowitz, O., Cohen, B., Maguen, S., Metzler, T., Lenoci, M., Blackburn, E., & Neylan, T. C. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.01.035 · Cited by 262 · cited 1×
“In individuals with post-traumatic stress disorder (PTSD), telomere shortening was more closely linked to adverse childhood events than to the PTSD per se.(44) The importance of accelerated telomere shortening for understanding comorbid medical illnesses and premature mortality in depressed individuals is highlighted…”
Self-citationDong, E., Matsumoto, K., Uzunova, V., Sugaya, I., Takahata, H., Nomura, H., Watanabe, H., Costa, E., & Guidotti, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051628598 · Cited by 261
Dhabhar, F. S., Burke, H. M., Epel, E. S., Mellon, S. H., Rosser, R., Reus, V. I., & Wolkowitz, O. M. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.05.010 · Cited by 225
Self-citationTelomeres and human aging: facts and fibs
Aviv, A. (2004) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2004.51.pe43 · Cited by 198
Sundström, I., Andersson, A., Nyberg, S., Ashbrook, D., Purdy, R. H., & Bäckström, T. (1998) · Neuroendocrinology · doi:10.1159/000054307 · Cited by 182
Cumurcu, B. E., Ozyurt, H., Etikan, I., Demir, S., & Karlidag, R. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.02004.x · Cited by 165
O’Donovan, A., Lin, J., Dhabhar, F. S., Wolkowitz, O., Tillie, J. M., Blackburn, E., & Epel, E. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2008.11.006 · Cited by 161
Hartmann, N., Boehner, M., Groenen, F., & Kalb, R. (2010) · Depression and Anxiety · doi:10.1002/da.20749 · Cited by 156
Ressler, K. J., Bradley, B., Mercer, K. B., Deveau, T. C., Smith, A. K., Gillespie, C. F., Nemeroff, C. B., Cubells, J. F., & Binder, E. B. (2010) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31052 · Cited by 140
Kopf, D., Westphal, S., Luley, C. W., Ritter, S., Gilles, M., Weber-Hamann, B., Lederbogen, F., Lehnert, H., Henn, F. A., Heuser, I., et al. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000138762.23482.63 · Cited by 92
Genetics of HPA-axis, depression and suicidality
Wasserman, D., Wasserman, J., & Sokolowski, M. (2010) · European Psychiatry · doi:10.1016/j.eurpsy.2009.12.016 · Cited by 63 · cited 1×
“Studies of the CRH-1 gene in humans, for example, have shown that specific variants are associated with differential hormonal responses to stress, and with differing rates of depression and suicidal behavior.(49) Increasingly, such genetic effects have themselves been found to be modulated by individual variation in e…”
Kleemeier Award Lecture 2008 – the canary in the coal mine: telomeres and human healthspan
Effros, R. B. (2009) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glp001 · Cited by 58
Thiazolidinediones: novel treatments for cognitive deficits in mood disorders?
McIntyre, R. S., Soczynska, J. K., Woldeyohannes, H. O., Lewis, G. F., Leiter, L. A., MacQueen, G. M., Miranda, A., Fulgosi, D., Konarski, J. Z., & Kennedy, S. H. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.11.1615 · Cited by 32
Chipman, P., Jorm, A. F., Tan, X.-Y., & Easteal, S. (2010) · Psychiatric Genetics · doi:10.1097/ypg.0b013e3283351140 · Cited by 24 · cited 2×
“A separate body of research has focused on genetic investigations in components of serotonergic function, most commonly on a variant in the serotonin promoter (5HTTLPR), and, to a lesser extent, on serotonin receptor genes.(55) In a small-scale study that remains controversial, Caspi et al(56) reported that the effect…”
Research works printed but not linked: 99
- 10.1016/S0378-5122(02)00012-9 · DOI · Paper page
- 10.3109/10401230701653377 · doi:10.3109/10401230701653377
- 10.1016/j.biopsych.2005.05.001 · DOI · Paper page
- 10.1001/archinte.160.12.1761 · DOI · Paper page
- 10.1080/15622970701875601 · DOI
- 10.14310/horm.2002.1217 · DOI · Paper page
- 10.3109/15622970109026799 · DOI
- SelyeH.The Stress of Life. New York, NY: McGraw-Hill.1956
- 10.1016/S0893-133X(99)00129-3 · DOI · Paper page
- 10.1073/pnas.97.1.325 · DOI · Paper page
- 10.1016/j.yfrne.2008.11.002 · DOI · Paper page
- 10.1176/appi.ajp.160.9.1554 · DOI · Paper page
- 10.1037/0022-3514.50.5.992 · DOI · Paper page
- 10.1023/A:1010630801589 · DOI
- 10.1073/pnas.0914568107 · DOI
- 10.1037/0022-3514.95.1.197 · DOI · Paper page
- 10.1001/archpsyc.1988.01800350021003 · DOI · Paper page
- 10.1016/j.jad.2003.12.013 · DOI · Paper page
- 10.1590/S1516-44462008000100012 · DOI · Paper page
- 10.1002/syn.20637 · DOI
- BarnesSK.OzanneSE.Pathways linking the early environment to longterm health and lifespan.Prog Biophys Mol Biol. In press.
- 10.1016/j.brainresbull.2005.09.015 · DOI
- 10.1016/j.biopsych.2009.08.014 · DOI · Paper page
- 10.1038/nn1276 · DOI · Paper page
- 10.1176/appi.ajp.2009.10030434 · DOI · Paper page
- 10.1385/ENDO:28:3:263 · DOI
- 10.1097/YCO.0b013e32833d16c1 · DOI
- 10.1523/JNEUROSCI.4214-09.2010 · DOI · Paper page
- KargK.BurmeisterM.SheddenK.SenS.The Serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation.Arch Gen Psychiatry. In press.
- 10.1016/j.biopsych.2005.10.026 · DOI · Paper page
- 10.1016/j.biopsych.2006.11.033 · DOI · Paper page
- MillerAH.Letter to the Editor Re: An inflammatory review of glucocorticoids in the CNS. Sorrells SF, Sapolsky RM.Brain Behavior Immun.200721259272988989; author reply 990.
- 10.1016/j.bbi.2006.11.006 · DOI · Paper page
- 10.1001/archpsyc.1987.01800210013002 · DOI
- 10.1176/ajp.152.2.265 · DOI
- BelanoffJ.SchatzbergAF.Glucocorticoid antagonists.Neuropsychopharmacology.200023S56
- 10.1097/00006842-199909000-00011 · DOI · Paper page
- 10.1002/14651858.CD005168.pub2 · DOI
- 10.1016/0166-2236(95)93942-Q · DOI · Paper page
- 10.1111/j.1749-6632.2009.04980.x · DOI · Paper page
- 10.1016/0165-1781(85)90088-5 · DOI
- 10.1073/pnas.95.6.3239 · DOI · Paper page
- 10.1016/S0006-3223(98)00070-5 · DOI
- 10.1159/000156467 · DOI · Paper page
- 10.1111/j.1582-4934.2008.00493.x · DOI
- 10.2174/156720507783018262 · DOI
- 10.1016/S0006-3223(98)00328-X · DOI · Paper page
- 10.1080/15622970310029901 · DOI
- 10.1016/S0074-7742(01)46065-X · DOI · Paper page
- 10.1677/joe.0.1580121 · DOI
- 10.1016/0306-4522(94)90330-1 · DOI · Paper page
- 10.1172/JCI119261 · DOI
- 10.1016/j.biopsycho.2005.02.007 · DOI
- 10.1055/s-0029-1237361 · DOI
- 10.1097/00006842-200203000-00010 · DOI · Paper page
- 10.1016/j.psyneuen.2006.11.009 · DOI · Paper page
- de LeonMJ.McRaeT.RusinekH.et al.Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease.J Clin Endocrinol Metab.199782325132599329348
- 10.1517/14656566.7.10.1305 · DOI
- 10.1016/j.neurobiolaging.2005.09.004 · DOI
- 10.1007/s00424-009-0721-8 · DOI
- 10.1161/01.CIR.0000163550.70487.0B · DOI · Paper page
- 10.1038/oby.2010.22 · DOI · Paper page
- 10.1093/jn/136.12.3022 · DOI · Paper page
- 10.1111/j.1749-6632.2008.03966.x · DOI · Paper page
- 10.1016/j.yjmcc.2006.08.005 · DOI
- 10.1016/S0079-6123(07)63020-9 · DOI · Paper page
- 10.1111/j.1365-2796.2007.01890.x · DOI · Paper page
- 10.1016/j.jpsychires.2005.01.009 · DOI
- 10.1007/s11064-005-6967-4 · DOI
- 10.1097/01.psy.0000195780.37277.2a · DOI · Paper page
- 10.1111/j.1440-1797.2006.00697.x · DOI
- 10.1002/pmic.200300924 · DOI
- 10.1038/sj.mp.4002075 · DOI · Paper page
- 10.1016/S0006-3223(01)01083-6 · DOI · Paper page
- 10.3109/15622971003611319 · DOI · Paper page
- 10.1038/npp.2010.114 · DOI · Paper page
- 10.1016/j.bbr.2009.03.040 · DOI
- 10.1097/00001756-200405190-00016 · DOI
- 10.1523/JNEUROSCI.22-24-10710.2002 · DOI
- 10.1007/s00125-007-0706-0 · DOI
- 10.1038/nm1006-1133 · DOI · Paper page
- 10.1097/YPG.0b013e32808374f6 · DOI
- 10.18632/aging.100007 · DOI · Paper page
- 10.4049/jimmunol.179.6.4249 · DOI · Paper page
- WolkowitzOM.MellonSH.EpelES.et al.Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response.Mol Psychiatry. In press.2011
- 10.1016/j.arr.2010.03.002 · DOI
- 10.1602/neurorx.1.1.111 · DOI
- 10.1111/j.1742-4658.2005.04677.x · DOI
- 10.1007/s11011-008-9118-1 · DOI · Paper page
- 10.1038/nrd2462 · DOI · Paper page
- 10.1002/hup.186 · DOI
- 10.2174/187152809789352221 · DOI
- 10.1016/S0006-8993(00)03108-5 · DOI · Paper page
- 10.1016/j.exger.2006.11.005 · DOI
- HarleyCB.LiuW.BlascoM.et al.A natural product telomerase activator as part of a health maintenance program.Rejuvenation Res. In press.
- 10.1001/jama.1983.03330250034024 · DOI · Paper page
- 10.1016/j.ceb.2010.04.011 · DOI
- 10.1016/j.ejphar.2007.12.032 · DOI · Paper page
- 10.1542/peds.65.4.862 · DOI
Cited by
Is depression associated with increased oxidative stress? A systematic review and meta-analysis
Black, C. N., Bot, M., Scheffer, P. G., Cuijpers, P., & Penninx, B. W. J. H. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.09.025 · Cited by 711
The effects of aging in the hippocampus and cognitive decline
Bettio, L. E. B., Rajendran, L., & Gil-Mohapel, J. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.04.030 · Cited by 649
Fredriksen-Goldsen, K. I., Simoni, J. M., Kim, H.-J., Lehavot, K., Walters, K. L., Yang, J., Hoy-Ellis, C. P., & Muraco, A. (2014) · American Journal of Orthopsychiatry · doi:10.1037/ort0000030 · Cited by 488
The circadian clock and pathology of the ageing brain
Kondratova, A. A., & Kondratov, R. V. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3208 · Cited by 482
Immune mechanisms linked to depression via oxidative stress and neuroprogression
Bakunina, N., Pariante, C. M., & Zunszain, P. A. (2015) · Immunology · doi:10.1111/imm.12443 · Cited by 444
Metadata
- Authors
- M. Wolkowitz, O., I. Reus, V., & H. Mellon, S.
- Venue
- Dialogues in Clinical Neuroscience
- Publisher
- Informa UK Limited
- Published
- 2011-03-31
- Volume
- 13
- Issue
- 1
- Pages
- 25-39
- ISSN
- 1294-8322 (ISSN-L)
- 1958-5969
- OpenAlex
- W1659146612
- Cited by
- 214
- References
- 59
- FWCI
- 6.94
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.